| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥105.2B | ¥98.8B | +6.4% |
| Operating Income | ¥-10.9B | ¥-15.3B | +57.1% |
| Ordinary Income | ¥-10.9B | ¥-15.4B | -14.1% |
| Net Income | ¥-11.2B | ¥-15.7B | -15.2% |
| ROE | -8.8% | -11.5% | - |
FY2026 Q3 cumulative results: Revenue 105.2B yen (YoY +6.4%), Operating Loss -10.9B yen (prior year loss -15.3B, deficit narrowed 28.8%), Ordinary Loss -10.9B yen (prior year loss -15.4B, improved 29.2%), Net Loss -11.2B yen (prior year loss -15.7B, deficit reduced 28.7%). The company achieved revenue growth but remains in operating deficit. Gross profit margin improved to 32.5%, yet selling, general and administrative expenses of 45.1B yen offset gross margin gains, resulting in an operating loss. Despite continued losses, the magnitude of deficits narrowed across all profit levels compared to prior year. Full year guidance projects return to profitability with operating income of 0.4B yen and net income of 0.2B yen, making Q4 execution critical.
[Profitability] ROE of -8.8% reflects net loss position, decomposed into net profit margin -10.7%, asset turnover 0.357x, and financial leverage 2.30x. Operating margin of -10.4% demonstrates operational efficiency challenges, though the deficit narrowed from prior year -15.5%. Gross profit margin of 32.5% indicates healthy product-level margins, but SG&A expenses representing 42.9% of revenue constrained profitability. Interest coverage ratio of -13.66x reflects insufficient operating profit to service interest expense. [Cash Quality] Cash and deposits of 47.6B yen provide 0.99x coverage of short-term borrowings of 48.3B yen, indicating limited short-term debt repayment buffer. Working capital indicators show inventory surged 109.8% YoY while receivables declined 55.5%, suggesting production-demand mismatch. [Investment Efficiency] Asset turnover of 0.357x (below industry median 0.58x) reflects lower asset utilization efficiency. Inventory turnover deteriorated with inventory balances doubling, indicating work-in-process accumulation. [Financial Health] Equity ratio of 43.5% (versus industry median 63.8%) and debt-to-equity ratio of 1.30x position leverage at moderate levels. Current ratio of 201.7% and quick ratio of 184.9% appear adequate, though short-term debt ratio of 54.4% concentrates refinancing risk. Interest-bearing debt totals 88.7B yen with debt-to-capital ratio of 40.9%.
Cash and deposits increased 10.1B yen YoY to 47.6B yen, primarily driven by working capital structural changes rather than operating profit generation given the loss position. Receivables declined sharply by 36.2B yen reflecting accelerated collection or sales mix changes, converting trade receivables to cash. Conversely, inventory surged 10.5B yen as work-in-process accumulated, tying up significant operating funds. The combination of receivables reduction and inventory buildup suggests timing mismatches between production schedules and order fulfillment. Electronic recorded payables increased 7.2B yen, providing supplier credit support to liquidity. Contract liabilities of 27.9B yen represent advance customer payments, offering working capital support though obligating future deliveries. Cash coverage of short-term borrowings stands at 0.99x, indicating refinancing dependency for 48.3B yen in short-term debt. The near-term priority involves converting elevated inventory back to cash through sales execution while managing short-term debt maturities.
Ordinary loss of -10.9B yen versus operating loss of -10.9B yen shows minimal non-operating impact, with non-operating income of 1.2B yen largely offset by non-operating expenses of 1.1B yen. Non-operating income comprised primarily of foreign exchange gains of 0.5B yen, representing 0.5% of revenue and indicating limited FX exposure. Interest expenses burden profitability given negative operating income, though absolute interest expense remains modest relative to revenue scale. The core earnings challenge stems from operating performance rather than non-operating factors, with SG&A expenses of 45.1B yen consuming 42.9% of revenue and overwhelming gross margin contribution. Receivables decreased substantially while inventory ballooned, creating an earnings quality concern regarding potential future write-downs if inventory proves slow-moving or obsolete. The deficit reduction of 4.4B yen in operating loss YoY demonstrates progress, though sustainability depends on Q4 achieving the guidance target of full-year operating profit. Contract liabilities provide some earnings visibility for revenue recognition upon delivery, though execution risk remains.
Inventory and work-in-process risk: Inventory increased 109.8% to 20.0B yen with significant work-in-process accumulation, creating exposure to obsolescence, write-downs, and cash tie-up. This 10.5B yen increase represents 10.0% of total assets and strains working capital efficiency. Production planning misalignment with demand could necessitate inventory provisions impacting future earnings.
Short-term refinancing and liquidity risk: Short-term debt ratio of 54.4% concentrates 48.3B yen in borrowings requiring near-term refinancing or repayment, while cash coverage stands at only 0.99x. Operating losses constrain cash generation capacity, elevating refinancing dependency and potential covenant pressure.
Q4 profitability execution risk: Full-year guidance projects 0.4B yen operating income requiring approximately 11.3B yen operating profit swing in Q4 to offset Q3 cumulative loss. This necessitates simultaneous SG&A reduction, inventory conversion to sales, and margin preservation. Failure to achieve Q4 targets would extend loss trajectory and pressure dividend sustainability despite projected 15 yen annual dividend.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE -8.8% substantially underperforms industry median 5.0%, placing the company in loss territory versus profitable peer median. Operating margin -10.4% trails industry median 8.3% by 18.7 percentage points, indicating significant operational efficiency gap. Net profit margin -10.7% versus industry median 6.3% reflects both operating underperformance and structural cost challenges.
Financial Health: Equity ratio 43.5% falls below industry median 63.8%, indicating higher leverage usage relative to peers. Current ratio 201.7% compares favorably to industry median 284.0%, though lower absolute level reflects higher current liabilities concentration. Financial leverage 2.30x exceeds industry median 1.53x, consistent with lower equity ratio positioning.
Efficiency: Asset turnover 0.357x lags industry median 0.58x, demonstrating below-average asset productivity. Inventory turnover deteriorated significantly with estimated days inventory outstanding well above industry median 108.81 days based on the 109.8% inventory increase. Receivables management appears stronger with the substantial collection improvement, though operating working capital turnover likely remains challenged given inventory buildup.
Growth: Revenue growth 6.4% outpaces industry median 2.7%, representing relative strength in top-line expansion. However, this growth has not translated to profitability, contrasting with industry peers maintaining positive margins.
Industry: Manufacturing sector (98 companies), Comparison: FY2025 Q3 median benchmarks, Source: Proprietary analysis
Revenue growth trajectory of 6.4% demonstrates market demand for the company's products, exceeding manufacturing sector median of 2.7%, yet profitability conversion remains the critical challenge. The combination of healthy gross margin at 32.5% with operating losses indicates the issue resides in cost structure rather than product competitiveness, specifically SG&A expenses consuming 42.9% of revenue versus gross margin contribution of 32.5%. Full-year guidance projecting operating income of 0.4B yen and net income of 0.2B yen implies Q4 must generate approximately 11.3B yen operating profit improvement, requiring evidence of SG&A reduction initiatives and inventory monetization progress.
Working capital management presents both risk and opportunity, with the 10.5B yen inventory increase representing tied-up funds that could strengthen cash position if successfully converted through sales execution. The sharp 36.2B yen receivables reduction demonstrates collection capability, but must be balanced against inventory accumulation to avoid simply shifting working capital composition. Short-term debt concentration of 48.3B yen with only 0.99x cash coverage necessitates monitoring refinancing actions and operating cash flow development in Q4 and beyond.
Dividend policy maintaining 12 yen year-end payment despite losses signals management confidence in recovery trajectory and shareholder return commitment, with full-year 15 yen guidance dependent on achieving profitability targets. Sustainability hinges on Q4 execution delivering the projected turnaround to positive earnings and beginning inventory normalization to strengthen cash generation capabilities.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.